Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Israeli Prime Minister Minister Benjamin Netanyahu receives the coronavirus vaccine. Photo: Miriam Alster/POOL/AFP via Getty Images
Israel has administered one vaccine dose to a a remarkable 44% of its population, with the UAE (26%), Seychelles (19%), U.K. (10%), Bahrain (8%) and U.S. (7%) following behind, per Our World in Data.
The flipside: Just 2% of EU residents have received their first shot, leading to consternation across the continent about the slow rollout.
- India has also run into early hurdles, including a malfunctioning appointments app and lower than expected uptake among health care workers, some of whom fear side effects, particularly from an Indian vaccine that was approved prior to phase three trials, per WSJ.
Good news: Early data from Israel suggests that almost no one who received both doses of the Pfizer vaccine has come down with a symptomatic case of COVID-19.
Between the lines: Two dozen countries are counting on Chinese vaccines, which Beijing had hoped would become a symbol of China's scientific development and global clout, the NY Times notes.
- But China has been slow to provide doses, and new data suggests the vaccines are less effective than expected. A YouGov poll of 17 countries found that most would distrust vaccines developed in China.
- Now, Chinese state media outlets are spreading disinformation casting doubts on the effectiveness of American and European vaccines.